Table 1.
PD, HD and control subjects’ age, sex and medical status. As medical status is defined the type of peritoneal dialysis followed, the underlying medical conditions and the medication received.
| PD patients | HD patients | Control | ||
|---|---|---|---|---|
| Age (years) Mean (±SD) | 22 to 92 59.4 (±17) | 20 to 94 61.9 (±15.2) | 23 to 67 45.2 (±14) | |
| N | ||||
| Sex | ||||
| Male | 25 | 41 | 25 | |
| Female | 14 | 20 | 15 | |
| Medical status | ||||
| Peritoneal dialysis type | CAPD | 25 | ||
| NIPD | 10 | |||
| IPD | 2 | |||
| CCPD | 2 | |||
| Medical conditions | ||||
| Hypertension | 38 | 26 | – | |
| Coronary heart disease (CHD) | 6 | 11 | – | |
| Peripheral artery disease (PAD) | 11 | 24 | – | |
| Cardiovascular disease (CVD) | 16 | 34 | – | |
| Diabetes | 10 | 19 | – | |
| Medication | ||||
| Statin treatment | 27 | 22 | – | |
| Alfacalcidol | 5 | 8 | – | |
| Paricalcitol | 13 | 11 | – | |
| ACE inhibitors | 6 | 3 | – | |
| Angiotensin receptor blockers (ARBs) | 20 | 11 | – | |
| Calcium channel blockers (CaChBI) | 22 | 15 | – | |
| Beta blockers | 36 | 35 | – | |
| Vitamin B supplement | 1 | 19 | – | |
Table Notes:
CAPD: continuous ambulatory peritoneal dialysis.
NIPD: nocturnal intermittent peritoneal dialysis.
IPD: intermittent peritoneal dialysis.
CCPD: continuous cycling peritoneal dialysis.